221 related articles for article (PubMed ID: 17380886)
1. [Immunochemical properties of West Nile virus protein prM and protein M C-end].
Bogachek MV; Protopopova EV; Ternovoĭ VA; Kachko AV; Ivanova AV; Ivanisenko VA; Shvalov AN; Loktev VB
Mol Biol (Mosk); 2007; 41(1):8-17. PubMed ID: 17380886
[TBL] [Abstract][Full Text] [Related]
2. [Immunochemical properties of short recombinant polypeptides of proteine of, the West Nile virus bearing epitopes of domains I and II].
Bogachek MV; Protopopova EV; Ternovoĭ VA; Kachko AV; Ivanova AV; Ivanisenko VA; Loktev VB
Mol Biol (Mosk); 2005; 39(5):813-22. PubMed ID: 16240715
[TBL] [Abstract][Full Text] [Related]
3. Strain analysis and epitope mapping of West Nile virus using monoclonal antibodies.
Damle RG; Yeolekar LR; Rao BL
Acta Virol; 1998 Dec; 42(6):389-95. PubMed ID: 10358745
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.
Li L; Barrett AD; Beasley DW
Virology; 2005 Apr; 335(1):99-105. PubMed ID: 15823609
[TBL] [Abstract][Full Text] [Related]
5. Delineation of an epitope on domain I of Japanese encephalitis virus Envelope glycoprotein using monoclonal antibodies.
Gangwar RS; Shil P; Cherian SS; Gore MM
Virus Res; 2011 Jun; 158(1-2):179-87. PubMed ID: 21477626
[TBL] [Abstract][Full Text] [Related]
6. Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus.
Ledizet M; Kar K; Foellmer HG; Bonafé N; Anthony KG; Gould LH; Bushmich SL; Fikrig E; Koski RA
J Infect Dis; 2007 Dec; 196(12):1741-8. PubMed ID: 18190253
[TBL] [Abstract][Full Text] [Related]
7. Human monoclonal antibodies to West Nile virus identify epitopes on the prM protein.
Calvert AE; Kalantarov GF; Chang GJ; Trakht I; Blair CD; Roehrig JT
Virology; 2011 Feb; 410(1):30-7. PubMed ID: 21084104
[TBL] [Abstract][Full Text] [Related]
8. Expression of recombinant West Nile virus prM protein fused to an affinity tag for use as a diagnostic antigen.
Setoh YX; Hobson-Peters J; Prow NA; Young PR; Hall RA
J Virol Methods; 2011 Jul; 175(1):20-7. PubMed ID: 21545809
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing monoclonal antibodies against Russian strain of the West Nile virus.
Razumov IA; Kazachinskaia EI; Ternovoi VA; Protopopova EV; Galkina IV; Gromashevskii VL; Prilipov AG; Kachko AV; Ivanova AV; L'vov DK; Loktev VB
Viral Immunol; 2005; 18(3):558-68. PubMed ID: 16212535
[TBL] [Abstract][Full Text] [Related]
11. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
[TBL] [Abstract][Full Text] [Related]
12. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S
Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus.
Throsby M; Geuijen C; Goudsmit J; Bakker AQ; Korimbocus J; Kramer RA; Clijsters-van der Horst M; de Jong M; Jongeneelen M; Thijsse S; Smit R; Visser TJ; Bijl N; Marissen WE; Loeb M; Kelvin DJ; Preiser W; ter Meulen J; de Kruif J
J Virol; 2006 Jul; 80(14):6982-92. PubMed ID: 16809304
[TBL] [Abstract][Full Text] [Related]
15. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein.
Balasuriya UB; Patton JF; Rossitto PV; Timoney PJ; McCollum WH; MacLachlan NJ
Virology; 1997 May; 232(1):114-28. PubMed ID: 9185595
[TBL] [Abstract][Full Text] [Related]
16. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
[TBL] [Abstract][Full Text] [Related]
17. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides.
Chassot S; Lambert V; Kay A; Godinot C; Roux B; Trepo C; Cova L
Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963
[TBL] [Abstract][Full Text] [Related]
18. Epitope detection in the envelope of intracellular naked orthopox viruses and identification of encoding genes.
Czerny CP; Johann S; Hölzle L; Meyer H
Virology; 1994 May; 200(2):764-77. PubMed ID: 7513922
[TBL] [Abstract][Full Text] [Related]
19. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
[TBL] [Abstract][Full Text] [Related]
20. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
Throsby M; Ter Meulen J; Geuijen C; Goudsmit J; de Kruif J
Expert Rev Vaccines; 2007 Apr; 6(2):183-91. PubMed ID: 17408368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
